Patient Perception of Vocal Tremor Severity and its Relationship to Acoustic Voice Outcomes: An Exploratory Study.

IF 1.9 Q2 CLINICAL NEUROLOGY
Tremor and Other Hyperkinetic Movements Pub Date : 2025-12-04 eCollection Date: 2025-01-01 DOI:10.5334/tohm.1087
James C Borders, Gary Gartling, Elizabeth Hary, Milan R Amin, Michelle S Troche, Julie Barkmeier-Kraemer, Ryan C Branski
{"title":"Patient Perception of Vocal Tremor Severity and its Relationship to Acoustic Voice Outcomes: An Exploratory Study.","authors":"James C Borders, Gary Gartling, Elizabeth Hary, Milan R Amin, Michelle S Troche, Julie Barkmeier-Kraemer, Ryan C Branski","doi":"10.5334/tohm.1087","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Vocal tremor profoundly impacts communication, social participation, and quality of life. Although expert auditory-perceptual ratings of vocal tremor severity align with acoustic voice outcomes (e.g., extent of frequency (<i>f</i> <sub>o</sub>) and intensity modulation), patient perception of their voice remains unexamined despite its clinical importance. This study aimed to characterize the relationship between patient-reported vocal tremor severity and acoustic voice outcomes at baseline and after botulinum toxin injections.</p><p><strong>Method: </strong>Patients diagnosed with vocal tremor affecting multiple structures (ETvt) or tremor only observed in the larynx (LDvt) were recruited. Participants completed the voice section of the Quality of Life in Essential Tremor questionnaire to assess patient perception and performed sustained /ɑ/ at a comfortable pitch and volume, from which acoustic voice outcomes (rate and extent of fundamental frequency [<i>f<sub>o</sub></i> ] and amplitude [dB] modulation) were derived. A subset of participants received botulinum toxin injections and were reassessed within the therapeutic window (within 12 weeks).</p><p><strong>Results: </strong>Thirty participants (29 females; mean age = 72 years, SD = 11.40) were analyzed. Participants who rated their vocal tremor as \"severe\" demonstrated higher rate <i>f<sub>o</sub></i> (β = 1.20, 95% CI: -0.10, 2.60 Hz) and rate dB (β = 2.30, 95% CI: 0.50, 4.10 Hz) compared to participants who rated their tremor as \"moderate\". Participants who rated their tremor as \"marked\" demonstrated higher rate <i>f<sub>o</sub></i> (β = 1.50, 95% CI: 0.30, 2.60 Hz) compared to \"moderate\" ratings. Improvements in patient perception of vocal tremor and acoustic outcomes were highly heterogenous among seven participants who received botulinum toxin.</p><p><strong>Discussion: </strong>Participants reporting more severe vocal tremor demonstrated more aberrant acoustic voice outcomes. After botulinum toxin injection, substantial heterogeneity was observed in acoustic voice measures which varied based on patient perception of change. These preliminary, exploratory findings provide a foundation for future investigations to define meaningful change in this population.</p>","PeriodicalId":23317,"journal":{"name":"Tremor and Other Hyperkinetic Movements","volume":"15 ","pages":"60"},"PeriodicalIF":1.9000,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12679986/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tremor and Other Hyperkinetic Movements","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5334/tohm.1087","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Vocal tremor profoundly impacts communication, social participation, and quality of life. Although expert auditory-perceptual ratings of vocal tremor severity align with acoustic voice outcomes (e.g., extent of frequency (f o) and intensity modulation), patient perception of their voice remains unexamined despite its clinical importance. This study aimed to characterize the relationship between patient-reported vocal tremor severity and acoustic voice outcomes at baseline and after botulinum toxin injections.

Method: Patients diagnosed with vocal tremor affecting multiple structures (ETvt) or tremor only observed in the larynx (LDvt) were recruited. Participants completed the voice section of the Quality of Life in Essential Tremor questionnaire to assess patient perception and performed sustained /ɑ/ at a comfortable pitch and volume, from which acoustic voice outcomes (rate and extent of fundamental frequency [fo ] and amplitude [dB] modulation) were derived. A subset of participants received botulinum toxin injections and were reassessed within the therapeutic window (within 12 weeks).

Results: Thirty participants (29 females; mean age = 72 years, SD = 11.40) were analyzed. Participants who rated their vocal tremor as "severe" demonstrated higher rate fo (β = 1.20, 95% CI: -0.10, 2.60 Hz) and rate dB (β = 2.30, 95% CI: 0.50, 4.10 Hz) compared to participants who rated their tremor as "moderate". Participants who rated their tremor as "marked" demonstrated higher rate fo (β = 1.50, 95% CI: 0.30, 2.60 Hz) compared to "moderate" ratings. Improvements in patient perception of vocal tremor and acoustic outcomes were highly heterogenous among seven participants who received botulinum toxin.

Discussion: Participants reporting more severe vocal tremor demonstrated more aberrant acoustic voice outcomes. After botulinum toxin injection, substantial heterogeneity was observed in acoustic voice measures which varied based on patient perception of change. These preliminary, exploratory findings provide a foundation for future investigations to define meaningful change in this population.

Abstract Image

Abstract Image

Abstract Image

患者对声带震颤严重程度的感知及其与声学语音结果的关系:一项探索性研究。
背景:声带震颤严重影响沟通、社会参与和生活质量。尽管专家对声带震颤严重程度的听觉感知评级与声学语音结果(例如,频率范围(f)和强度调制)一致,但尽管其临床重要性,患者对其声音的感知仍未得到检查。本研究旨在描述患者报告的声带震颤严重程度与基线和注射肉毒杆菌毒素后声学语音结果之间的关系。方法:选取经诊断为声带震颤及多处震颤(ETvt)或仅喉部震颤(LDvt)的患者。参与者完成特发性震颤患者生活质量问卷的声音部分,以评估患者的感知能力,并在舒适的音调和音量下进行持续/音/音,由此得出声学语音结果(基频[fo]和振幅[dB]调制的速率和程度)。一部分参与者接受肉毒杆菌毒素注射,并在治疗窗口(12周内)重新评估。结果:共纳入30例受试者,其中女性29例,平均年龄72岁,SD = 11.40。与将自己的震颤评为“中度”的参与者相比,将自己的震颤评为“严重”的参与者表现出更高的比率(β = 1.20, 95% CI: -0.10, 2.60 Hz)和比率dB (β = 2.30, 95% CI: 0.50, 4.10 Hz)。将自己的震颤评定为“明显”的参与者比评定为“中度”的参与者表现出更高的震颤率(β = 1.50, 95% CI: 0.30, 2.60 Hz)。在接受肉毒杆菌毒素治疗的7名患者中,患者对声带震颤的感知和声学结果的改善是高度异质性的。讨论:报告更严重的声音震颤的参与者表现出更多的异常声音结果。注射肉毒杆菌毒素后,观察到声学声音测量的实质性异质性,其根据患者对变化的感知而变化。这些初步的探索性发现为未来的调查提供了基础,以确定这一人群中有意义的变化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.00
自引率
4.50%
发文量
31
审稿时长
6 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书